Clinical Trial Update: Cohort Study on Sequential ADC Therapy in HR-positive/HER2-negative Advanced Breast Cancer [Phase 4]

View source ↗

Summary

A Phase 4 cohort study update on sequential antibody-drug conjugate therapy for HR-positive/HER2-negative advanced breast cancer; the trial status is NOT_YET_RE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Yan Xue | Conditions: Breast Neoplasms | Phase 4 | Status: NOT_YET_RECRUITING